Recent News for MNTA - Momenta Pharmaceuticals, Inc.

Date Title
Jan 21 Novartis (NVS) Gets Approval for MS Drug Mayzent in Europe
Jan 16 The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics
Jan 15 Momenta Pharmaceuticals (MNTA) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
Jan 15 Healthcare - Top 5 Gainers / Losers
Jan 15 NIO, NVAX among premarket gainers
Jan 15 Momenta (MNTA) Provides Pipeline Updates, Stock Rallies
Jan 15 Momenta Rockets After Analysts Get Bullish on Biopharma's Newest Treatment
Jan 14 Momenta adds to rally as JPMorgan upgrades
Jan 14 OGI, NKTR, TCOM and VHC among after hour movers
Jan 13 Momenta Provides Year-End 2019 Update and 2020 Outlook
Jan 3 Momenta finance chief bids adieu
Jan 3 Momenta Pharmaceuticals Announces CFO Transition
Dec 24 Momenta Pharmaceuticals to Webcast Presentation at the 38th Annual J.P. Morgan Healthcare Conference
Dec 24 The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict
Dec 18 The Daily Biotech Pulse: Positive Adcom Verdict For Merck, Homology Medicine Slips On Mixed Gene Therapy Efficacy Data
Dec 13 Momenta Pharmaceuticals (MNTA) Catches Eye: Stock Jumps 7.1%
Dec 13 Momenta Pharmaceuticals Appoints Dr. Jane F. Barlow to Board of Directors
Dec 12 Momenta Pharma prices $225M equity offering
Dec 12 Momenta Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Dec 12 13 Healthcare Stocks Moving In Thursday's Pre-Market Session
Dec 11 Microbot Medical leads healthcare gainers; Correvio Pharma tops the losers
Dec 11 The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint
Dec 11 Did Hedge Funds Drop The Ball On Momenta Pharmaceuticals, Inc. (MNTA) ?
Dec 10 Momenta to pay $35M to settle Tennessee antitrust case
Dec 10 Momenta Pharma launches $200M stock offering

Back to the Main MNTA Page...